Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders.
Millan MJ, Rivet JM, Gobert A. Millan MJ, et al. Among authors: rivet jm. J Psychopharmacol. 2016 Nov;30(11):1099-1128. doi: 10.1177/0269881116672342. Epub 2016 Oct 17. J Psychopharmacol. 2016. PMID: 27756833 Review.
Simultaneous quantification of D- vs. L-serine, taurine, kynurenate, phosphoethanolamine and diverse amino acids in frontocortical dialysates of freely-moving rats: differential modulation by N-methyl-D-aspartate (NMDA) and other pharmacological agents.
Gobert A, Rivet JM, Billiras R, Parsons F, Millan MJ. Gobert A, et al. Among authors: rivet jm. J Neurosci Methods. 2011 Nov 15;202(2):143-57. doi: 10.1016/j.jneumeth.2011.08.040. Epub 2011 Sep 6. J Neurosci Methods. 2011. PMID: 21920385
Quantification of extracellular levels of corticosterone in the basolateral amygdaloid complex of freely-moving rats: a dialysis study of circadian variation and stress-induced modulation.
Bouchez G, Millan MJ, Rivet JM, Billiras R, Boulanger R, Gobert A. Bouchez G, et al. Among authors: rivet jm. Brain Res. 2012 May 3;1452:47-60. doi: 10.1016/j.brainres.2012.01.010. Epub 2012 Jan 16. Brain Res. 2012. PMID: 22464880
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
Dekeyne A, Brocco M, Loiseau F, Gobert A, Rivet JM, Di Cara B, Cremers TI, Flik G, Fone KC, Watson DJ, Papp M, Sharp T, Serres F, Cespuglio R, Olivier B, Chan JS, Lavielle G, Millan MJ. Dekeyne A, et al. Among authors: rivet jm. J Pharmacol Exp Ther. 2012 Mar;340(3):765-80. doi: 10.1124/jpet.111.187534. Epub 2011 Dec 16. J Pharmacol Exp Ther. 2012. PMID: 22178753
S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and paroxetine.
Millan MJ, Dekeyne A, Gobert A, Mannoury la Cour C, Brocco M, Rivet JM, Di Cara B, Lejeune F, Cremers TI, Flik G, de Jong TR, Olivier B, de Nanteuil G. Millan MJ, et al. Among authors: rivet jm. Eur Neuropsychopharmacol. 2010 Sep;20(9):599-621. doi: 10.1016/j.euroneuro.2010.04.003. Epub 2010 May 18. Eur Neuropsychopharmacol. 2010. PMID: 20483567
S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.
Dekeyne A, Mannoury la Cour C, Gobert A, Brocco M, Lejeune F, Serres F, Sharp T, Daszuta A, Soumier A, Papp M, Rivet JM, Flik G, Cremers TI, Muller O, Lavielle G, Millan MJ. Dekeyne A, et al. Among authors: rivet jm. Psychopharmacology (Berl). 2008 Sep;199(4):549-68. doi: 10.1007/s00213-008-1177-9. Epub 2008 Jun 4. Psychopharmacology (Berl). 2008. PMID: 18523738
The melanin-concentrating hormone1 receptor antagonists, SNAP-7941 and GW3430, enhance social recognition and dialysate levels of acetylcholine in the frontal cortex of rats.
Millan MJ, Gobert A, Panayi F, Rivet JM, Dekeyne A, Brocco M, Ortuno JC, Di Cara B. Millan MJ, et al. Among authors: rivet jm. Int J Neuropsychopharmacol. 2008 Dec;11(8):1105-22. doi: 10.1017/S1461145708008894. Epub 2008 May 9. Int J Neuropsychopharmacol. 2008. PMID: 18466669
S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects.
Millan MJ, Loiseau F, Dekeyne A, Gobert A, Flik G, Cremers TI, Rivet JM, Sicard D, Billiras R, Brocco M. Millan MJ, et al. Among authors: rivet jm. J Pharmacol Exp Ther. 2008 Mar;324(3):1212-26. doi: 10.1124/jpet.107.134536. Epub 2007 Dec 20. J Pharmacol Exp Ther. 2008. PMID: 18096759
The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis.
Millan MJ, Gobert A, Roux S, Porsolt R, Meneses A, Carli M, Di Cara B, Jaffard R, Rivet JM, Lestage P, Mocaer E, Peglion JL, Dekeyne A. Millan MJ, et al. Among authors: rivet jm. J Pharmacol Exp Ther. 2004 Oct;311(1):190-203. doi: 10.1124/jpet.104.069625. Epub 2004 May 14. J Pharmacol Exp Ther. 2004. PMID: 15146031
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
Millan MJ, Cussac D, Gobert A, Lejeune F, Rivet JM, Mannoury La Cour C, Newman-Tancredi A, Peglion JL. Millan MJ, et al. Among authors: rivet jm. J Pharmacol Exp Ther. 2004 Jun;309(3):903-20. doi: 10.1124/jpet.103.062398. Epub 2004 Feb 20. J Pharmacol Exp Ther. 2004. PMID: 14978194
75 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback